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Tragopogon porrifolius (Asteraceae), commonly referred to as white salsify, is an edible herb used in Lebanese folk medicine to treat
cancer and liver dysfunction. In this study, we investigated the antioxidant activity of Tragopogon porrifolius methanolic extract,
both in vitro and in vivo, in addition to its hepatoprotective and anticancer activities. Total phenolic and flavonoid contents were
measured and found to be 37.0 ± 1.40mgGAE/g and 16.6 ± 0.42mgQE/g dry weight, respectively. In vitro antioxidant assays
revealed an FRAP value of 659 ± 13.8 𝜇mol Fe2+/g of extract and DPPH IC
50
value 15.2𝜇g/mL. In rats subjected to CCl
4
-induced
hepatotoxicity, significant increase in CAT, SOD, and GST levels was detected.The highest dose of the extract (250mg/kg) recorded
a fold increase of 1.68 for SOD, 2.49 for GST, and 3.2 for CAT. The extract also showed substantial decrease in AST (57%), ALT
(56%), and LDH (65%) levels. Additionally, the extract caused a dose-dependent decrease in cell viability and proliferation. In
conclusion, the methanolic extract of T. porrifolius displayed a relatively high antioxidant activity both in vitro and in vivo as well
as hepatoprotective potential against liver toxicity in rats and anticancer effect on MDA-MB-231 and Caco-2 cells.
1. Introduction
Oxygen free radicals or reactive oxygen species (ROS),
including the superoxide radical O
2
∙−, hydrogen peroxide
H
2
O
2
, and the highly reactive hydroxyl radical ∙OH, are
extremely reactive molecules and can oxidize lipids, proteins,
and even DNA. They are normally present in a balance
with antioxidants molecules that improve the body’s cellular
defense system against oxidative damage. Antioxidants help
maintain lower levels of free radicals; thus they perform
beneficial physiological roles [1, 2]. The antioxidant defense
systemof the body can be in the formof lowmolecular weight
antioxidants such as vitamins E and C which block free radi-
cals, or in the form of enzymes such as superoxide dismutase,
catalase, and the glutathione system (glutathione, glutathione
reductase, peroxidase, and transferase) that reduce the levels
of reactive oxygen species [3, 4]. When an imbalance occurs
between free radicals and the antioxidant defense system, this
may result in oxidative stress, which has been shown to be
involved in the initiation and progression of various human
diseases, including cancer [2, 3]. DNA damage induced
by both exogenous and endogenous free radicals is well
documented and widely accepted to be a major cause of
genomic instability and cancer. Human studies have shown
that oxidative DNAdamage is an important carcinogenic and
mutagenic factor in the sense that it favors the acquisition
of mutations and contributes to cellular transformation and
cancer cell survival [2].
According to the World Health Organization [5], 80% of
the population of developing countries inAsia andAfrica rely
on traditional medicine for primary health care. Resorting
to traditional medicine in order to discover plants with
therapeutic properties has proven valuable in the search
for new bioactive compounds [6]. In fact, in recent years,
concerns over harmful side effects of synthetic compounds
have shifted the focus to natural plant resources, which
represent an abundant source of biologically activemolecules
[7]. Taking into account that only 1% of the estimated 500,000
plant species on Earth have been investigated, the need for
novel medicinal bioactive compounds is substantial [7].
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Tragopogon porrifolius, Asteraceae family, is an edible
herb and is commonly known as salsify, oyster plant, and
vegetable oyster. T. porrifolius is widespread throughout the
Mediterranean region where it grows wild and is cultivated.
All parts of the plant are edible, the roots, leafy shoots, and
open flowers are used as being both cooked and raw [8],
and, in Lebanon, the shoots are more frequently consumed
than the roots. The nutritional value of this plant has been
attributed to its monounsaturated and essential fatty acids,
vitamins, polyphenols, and fructooligosaccharides compo-
nents [9]. Recent studies in our laboratory revealed that
intake of aqueous extract of T. porrifolius caused improve-
ment of lipemia and increased satiety in rats with no visible
adverse effects [10]. Additionally, methanol, ethyl acetate,
and chloroform extracts of aerial parts of T. porrifolius
demonstrated anti-inflammatory effects in mice [11].
To the best of our knowledge, no studies were conducted
on T. porrifolius to investigate its antioxidant, hepatopro-
tective, and anticancer activities. Therefore, this study was
carried out to evaluate the in vitro and in vivo antioxidant
activities of the plant methanolic extract and its hepatopro-
tective effect against CCl
4
-induced liver damage in rats, in
addition to its cancer activity against colon (Caco-2) and
breast (MDA-MB-231) cancer cell lines.
2. Materials and Methods
2.1. Plant Material and Extraction. The T. porrifolius plant
material was collected from south of Lebanon and air-dried in
the shade. The dried plant material was cut into small pieces
and soaked inmethanol for 72 hours and the extract was then
filtered using Whatman no. 1 filter paper. This process was
repeated twice to ensuremaximal extraction.The solvent was
removed under reduced pressure using a rotary evaporator
(40∘C, 337mbar) and the residue was dried under vacuum
(9.23% yield) and stored at −20∘C until use.
2.2. Determination of Total Phenolic Content. Total phenolic
content was estimated by the Folin-Ciocalteu colorimetric
method, based on the procedure of Singleton and Rossi [12]
using gallic acid (100–1000mg/L in 80%methanol) as a stan-
dard. Briefly, 50 𝜇Lof the 1 : 5 diluted andfiltered extract (at an
original concentration of 100mg/mL inmethanol) wasmixed
with 450𝜇L of distilled water and 2.5mL of 0.2N Folin-
Ciocalteu reagent. After 5min, 2mL of saturated sodium
carbonate (75 g/L) was added and the mixture was incubated
at 30∘C for 90 minutes with intermittent shaking. The
absorbance of the resulting blue-colored solution was mea-
sured at 765 nm and the total phenolic content was expressed
as mg gallic acid equivalents (GAE)/g of dry weight extract.
2.3. Determination of Total Flavonoid Content. Total flavo-
noid content was determined by the aluminum chloride
colorimetric method described by Chang et al. [13] using
quercetin (10–100mg/L) as a standard. Briefly, 500𝜇L of the
1 : 20 diluted and filtered extract (at an original concentration
of 100mg/mL in methanol) was mixed with 1.5mL of 95%
methanol, 100 𝜇L of 10% aluminum chloride (AlCl
3
), 100 𝜇L
of 1M potassium acetate (CH
3
COOK), and 2.8mL of deion-
ized water. The mixture was incubated at room temperature
for 40 minutes and the absorbance was measured at 415 nm.
The total flavonoid content was expressed as quercetin
equivalents mg (QE)/g dry weight extract.
2.4. HPLC Analysis of T. porrifolius Methanolic Extract. The
phenolic acids and flavonoids were analyzed using Shimadzu
HPLC system (Shimadzu Corp., Kyoto, Japan) consisting of
LC 10-ADVP pump, SCL 10A system controller coupled with
a photo-diode array detector (SPD-M20A), FCV-10AL low
pressure gradient, Rheodyne injector (Model 7125), DGU-
20A online degasser, Shim-pack VP-ODS column, (4.6mm
i.d. × 150mm), and precolumn (10 × 4.6mm i.d. 5 𝜇m)
equipped with LC solution 1.23 SP1 software (Shimadzu,
Kyoto, Japan). The column was operated at 25∘C. The mobile
phase consisted of water : acetic acid :methanol (10 : 2 :
88 v/v) as solvent A, andwater : acetic acid :methanol (90 : 2 :
8 v/v) as solvent B at a flow rate of 1.5mL/min. The gradient
elution program was as follows: 0–15min solvent A and 15–
30min solvent followed by washout period for 10min and the
wavelength of detectionwas set at 280 nm.The phenolic acids
and flavonoids were identified bymatching the retention time
and their spectral characteristics with those of the standard
compounds.
All phenolic acids and flavonoid standards (gallic acid,
chlorogenic acid, vanillic acid, syringic acid, caffeic acid,
ellagic acid, myricetin, quercetin, luteolin, kaempferol, and
apigenin) were purchased from Sigma-Aldrich Co. (St. Louis,
MO, USA). All HPLC solvents were purchased from Merck
(Germany). The standard stock solutions (0.2mg/mL) were
prepared by dissolving each standard inmethanol and diluted
with the mobile phase in the range of 10–60 𝜇g/mL.
2.5. In Vitro Antioxidant Assays
2.5.1. FRAP Assay. The FRAP value was calculated based
on the method of Benzie and Strain [14] using ferrous
sulphate (10–100mM FeSO
4
⋅7H
2
O) as a standard. Briefly,
20𝜇L of either the extract or different concentrations of the
ferrous sulphate standard was added to 150 𝜇L of the freshly
prepared and prewarmed (at 37∘C) FRAP reagent (300mM
acetate buffer at a pH of 3.6, 10mM2,4,6-tripyridyl-s-triazine
(TPTZ) in 40mM HCl, and 20mM ferric chloride solution
in a 10 : 1 : 1 ratio). The absorbance was measured after 8
minutes in an ELISAmicroplate reader at 600 nm.The FRAP
value (𝜇M ferric ions reduced to ferrous form per gram) of
each sample was determined after subtracting the blank read-
ing.
2.5.2. DPPH Assay. The DPPH assay is based on the ability
of this stable radical to react with hydrogen donors [15].
Briefly, 50𝜇L of the extract (10, 50, and 100 𝜇g/mL) and
50 𝜇L of 0.5mM DPPH in ethanol were added to each well
and incubated in the dark for 40 minutes. The absorbance
was read at 492 nm. Ascorbic acid and Trolox were used
as reference compounds and the radical scavenging activity
was calculated as percentage inhibition of absorbance. IC
50
,
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the concentration needed to reduce the initial absorbance of
DPPH radical by 50%, was determined.
2.6. CCl
4
-Induced Hepatotoxicity Model. Male Wistar rats
weighing 180–220 g (Lebanese American University stock)
were housed under stable conditions of temperature (20 ±
2
∘C) and humidity (50 ± 5%) and an alternating cycle
of light and dark (12 hr). The animals were supplied with
standard laboratory rat chow diet andwater. All experimental
protocols were approved by theDepartmental Animal Ethical
Committee of the Lebanese American University, which
complies with the Guide for the Care and Use of Laboratory
Animals (Committee for theUpdate of theGuide for the Care
and Use of Laboratory Animals, 2010).
Liver damage was induced with CCl
4
in a 1 : 1 (v/v)
mixture with olive oil at a dose of 1.5mL/kg administered
intraperitoneally [16]. The rats were divided into 8 groups of
6 animals each. Group I was untreated and served as normal
control. Groups II and III received T. porrifolius methanolic
extract in DMSO (50 and 250mg/kg, i.p.) for 6 days. Group
IV only received CCl
4
/olive oil (1.5mL/kg, i.p.) for the last
3 days of treatment. Group V received DMSO (2mL/kg)
for 6 days, in combination with CCl
4
/olive oil (1.5mL/kg,
i.p) for the last 3 days of treatment (vehicle group). Groups
VI, VII, and VIII were treated for 6 days with T. porrifolius
methanolic extract in DMSO (50, 100, and 250mg/kg, i.p),
in combination with CCl
4
/olive oil (1.5mL/kg, i.p) for the
last 3 days of treatment. 48 hours after treatment, the animals
were sacrificed and serum samples were tested for AST, ALT,
and LDH using commercial kits (SPINREACT). Also, the
liver of each animal was excised and homogenized in 0.1M
phosphate buffer (pH 7.0) containing 0.1% Triton X-100.
The homogenate was centrifuged at 19,000 g for 10 minutes
and the supernatant was used for the determination of total
protein (Bio-Rad Protein Assay Kit II) and activity of the
antioxidant enzymes CAT, SOD, and GST.
2.6.1. CAT Assay. Catalase activity was assayed at 25∘C
according to a method described by Pedraza-Chaverr´ı et
al. (2001) based on H
2
O
2
disappearance [17]. The reaction
betweenH
2
O
2
and CAT follows a first-order kinetics as given
by the equation 𝑘 = 2.3/𝑡 log𝐴
0
/𝐴, where 𝑘 is the first-
order reaction rate constant, 𝑡 is the time over which the
disappearance of H
2
O
2
was measured (15 sec), and 𝐴
0
/𝐴
is the optical density at times 0 and 15 s, respectively. The
reaction was carried out by mixing 5𝜇L aliquots of the 1 : 40
diluted supernatant and 720𝜇L of 30mM H
2
O
2
in 10mM
potassium phosphate solution. The decomposition of H
2
O
2
by CAT present in the samples was measured at 240 nm for
a period of 15 seconds. The results were expressed in k/mg
protein.
2.6.2. SOD Assay. SOD activity was assayed according to the
method of S. Marklund and G. Marklund [18]. Briefly, 50 𝜇L
of the homogenized liver supernatant was added to 2.8mL
Tris-EDTA (50mMTris, 1.2mMEDTA, pH= 8.5) and 100𝜇L
of 2mM pyrogallol at 25∘C. The optical density (OD) of the
mixture was read at zero and three minutes at 420 nm against
the control which consisted of Tris-EDTA and pyrogallol.
One unit of SOD is the amount of enzyme that inhibits the
rate of autooxidation of pyrogallol by 50%. The results were
calculated according to the following equations:
Rate (𝑅) = (final OD − initial OD)
3
,
% inhibition = [
(𝑅control − 𝑅)
𝑅control
] × 100,
Enzyme unit (𝑈) = (% inhibition
50
) × dilution factor.
(1)
2.6.3. GST Assay. GST activity was determined according
to the method of Habig et al. [19]. This procedure is based
on the conjugation of glutathione (GSH) to 1-chloro-2,4-
dinitrobenzene (CDNB) as a substrate. Briefly, 600 𝜇L of the
liver homogenate supernatant fractionwas added to 2.2mLof
0.1M potassium phosphate buffer (pH 6.5), 100𝜇L of 30mM
CDNB, and 100 𝜇L of 30mM GSH. After adding CDNB the
change in absorbance at 340 nm was determined at 37∘C as
a function of time and the activity of GST was expressed
in nmol of GSH-CDNB conjugates formed/min/mg protein
using an extinction coefficient of 9.6mM−1 cm−1.
2.7. Cell Culture and Treatment. MDA-MB-231 (human
breast adenocarcinoma) and Caco-2 (human colorectal ade-
nocarcinoma) cell lines were used to assess cytotoxicity and
antiproliferation effects. Both cell lines were maintained in
Dulbecco’smodified Eagle’s medium (DMEM) supplemented
with 10% v/v heat-inactivated fetal bovine serum (FBS),
100 𝜇g/mL streptomycin, and 100U/mL penicillin. Cells were
incubated at 37∘C in a humidified atmosphere of 5% CO
2
.
2.7.1. Cytotoxicity Assay. Cytotoxicity of the T. porrifolius
methanolic extract (5, 10, 25, 50, and 100 𝜇g/mL) on the cell
lines was assayed at 24 and 48 hours using the Trypan Blue
exclusion method. Cells were trypsinized, diluted in 0.4%
TrypanBlue, and counted in a hemocytometer chamber. Cells
were plated in triplicate and experiments were repeated three
times.
2.7.2. Proliferation Assay. The effect of the T. porrifolius
methanolic extract (5, 10, 25, 50, and 100 𝜇g/mL) on cell
proliferation was measured at 24 and 48 hours using the
cell proliferation reagent WST-1 (Roche Applied Science,
Penzberg, Germany), a tetrazolium salt which is cleaved
by mitochondrial dehydrogenases in metabolically active
cells. The intensity of produced formazan was measured at
440 nm using amicroplate ELISA reader. Cells were plated in
triplicate and experiments were repeated three times.
2.8. Statistical Analysis. Data was analyzed for statistical
significance using one-way analysis of variance (ANOVA).
Values of the different tested parameters within each group
are presented asmean± SEM.All data were analyzedwith the
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Figure 1: (a) HPLC chromatogram of a standard mixture of phenolic acids and flavonoids. Peaks: 1 = gallic acid; 2 = chlorogenic acid; 3 =
vanillic acid; 4 = syringic acid; 5 = caffeic acid; 6 = ellagic acid; 7 = myricetin; 8 = quercetin; 9 = luteolin; 10 = kaempferol; 11 = apigenin. (b)
HPLC chromatogram of Tragopogon porrifoliusmethanolic extract.
Table 1: In vitro antioxidant activity of T. porrifolius methanolic
extract in comparison to ascorbic acid and Trolox, as calculated by
the FRAP and DPPH assays. Values denote mean ± SEM (𝑛 = 5).
FRAP value
(𝜇mol Fe2+/g)
DPPH assay-IC50
(𝜇g/mL)
T. porrifolius
methanolic extract 659.57 ± 13.77 15.18
Ascorbic acid 889.27 ± 17.13 9.13
Trolox 1349.86 ± 53.41 6.82
statistical package SPSS 18, and differences between groups
were considered statistically significant if 𝑃 < 0.05.
3. Results
3.1. Total Phenolic and Flavonoid Contents. Total phenolic
content of the methanolic extract of T. porrifolius was
estimated by the Folin-Ciocalteu colorimetric method using
gallic acid to generate the standard curve andwas determined
to be 37.0 ± 1.4mg GAE/g dry weight. Total flavonoid
contentwas estimated by the aluminumchloride colorimetric
method using quercetin to generate the standard curve and
was determined to be 16.6 ± 0.42mg QE/g dry weight.
3.2. In Vitro Antioxidant Activity. The in vitro antioxidant
activity of the T. porrifolius methanolic extract was deter-
mined by two methods: the FRAP assay and the DPPH free
radical scavenging assay. Results shown in Table 1 reveal that
the FRAP value and IC
50
value of DPPH were 659 𝜇mol
Fe2+/g and 15.2 𝜇g/mL, respectively.
3.3. HPLC Analysis of T. porrifolius Methanolic Extract. The
T. porrifolius methanolic extract was subjected to HPLC
analysis and the results are displayed in Figure 1. The HPLC
chromatogram showed several peaks, and only four peaks
matched with the standards with retention times 2.13, 5.88,
31.35, and 32.4min were identified as gallic acid (1.60 𝜇g/mg),
chlorogenic acid (13.9 𝜇g/mg), quercetin (15.4 𝜇g/mg), and
luteolin (35.34 𝜇g/mg), respectively, by comparing their
retention times and UV spectra.
3.4. Hepatoprotective Activity. Treatment of normal rats with
T. porrifolius methanolic extract (50 and 250mg/kg body
weight) did not significantly affect the activities of AST, ALT,
and LDH (Table 2). As expected, the groups subjected to liver
damage with CCl
4
/olive oil showed tremendous increases
in the levels of these enzymes (Table 2). However, pretreat-
ment with the extract (50, 100, and 250mg/kg) exhibited
a significant hepatoprotective capacity as compared to the
control (group V) that received DMSO + CCl
4
/olive oil. The
aforementioned doses caused significant reduction in levels
of AST by 26.9, 40.2, and 51.7%, ALT by 17.9, 31.8, and 50.7%,
and LDH by 30.5, 48.8, and 61.1%, respectively.
The in vivo antioxidant activity of T. porrifoliusmethano-
lic extract was determined by evaluating the activities of
CAT, GST, and SOD in the livers of both normal and CCl
4
-
treated animals (Table 3). Treatment of normal rats with
the lowest and highest doses of the extract increased the
activities of these enzymes, with significance reached at
250mg/kg body weight. CCl
4
treatment significantly lowered
the activities of CAT, GST, and SOD as compared to the
normal group. However, groups pretreated with the extract
showed a significant dose-dependent increase in the activities
of these enzymes whichwere restored to normal at 250mg/kg
body weight dose.
3.5. Effects of T. porrifolius Methanolic Extract on Cytotoxicity
andCell Proliferation. Thecytotoxic effect of theT. porrifolius
methanolic extract was also examined. In bothMDA-MB-231
(Figure 2) and Caco-2 (Figure 3), the cells showed a decrease
in cell viability that is both time- and dose-dependent. The
MDA-MB-231 cells showed between 25% and 35% increase
in dead cells after treatment with 100𝜇g/mL of the extract
at 24 and 48 hours (Figure 2(a)). Similarly, the Caco-2 cells
showed between 20% and 30% increase in dead cells after
treatment with 100 𝜇g/mL of the extract at 24 and 48 hours
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Table 2: Effect of T. porrifoliusmethanolic extract on the activities of liver antioxidant enzymes. Values denote mean ± SEM (𝑛 = 6).
Group CAT (k/mg) GST (nmol/min/mg) SOD (units)
I Normal (no treatment) 4.77 ± 0.54 7.37 ± 0.52 13.44 ± 0.60
II T. porrifolius 50mg/kg 5.85 ± 0.81 8.51 ± 0.73 15.25 ± 0.68
III T. porrifolius 250mg/kg 8.51 ± 0.54a 9.54 ± 0.65a 17.00 ± 0.56a
IV CCl4/olive oil 1.05 ± 0.12
a 0.92 ± 0.13a 6.33 ± 0.74a
V DMSO + CCl4/olive oil 1.43 ± 0.11
a 2.35 ± 0.51a 8.38 ± 0.52a
VI T. porrifolius 50mg/kg + CCl4/olive oil 2.46 ± 0.34ab 1.64 ± 0.16a 10.32 ± 0.91a
VII T. porrifolius 100mg/kg + CCl4/olive oil 3.19 ± 0.35ab 3.19 ± 0.41a 10.91 ± 0.63ab
VIII T. porrifolius 250mg/kg + CCl4 4.61 ± 0.27b 5.86 ± 0.65b 14.11 ± 0.73b
a
𝑃 < 0.05 with respect to the normal group (no treatment).
b
𝑃 < 0.001 with respect to the vehicle group (DMSO + CCl4/olive oil).
Table 3: Effect of T. porrifoliusmethanolic extract on the activities of liver function enzymes in serum. Values denote mean ± SEM (𝑛 = 6).
Group AST (U/L) ALT (U/L) LDH (U/L)
I Normal (no treatment) 61.83 ± 2.44 33.44 ± 2.63 312.74 ± 53.27
II T. porrifolius 50mg/kg 60.76 ± 0.86 35.58 ± 1.20 315.2 ± 16.74
III T. porrifolius 250mg/kg 67.81 ± 1.54 38.35 ± 2.45 369.37 ± 27.17
IV CCl4/olive oil 137.57 ± 9.03 66.30 ± 4.10 798.40 ± 53.57
V DMSO + CCl4/olive oil 122.89 ± 14.22 58.62 ± 4.24 727.53 ± 96.12
VI T. porrifolius 50mg/kg + CCl4/olive oil 89.83 ± 8.20∗ 48.12 ± 5.71 505.63 ± 62.30∗
VII T. porrifolius 100mg/kg + CCl4/olive oil 73.5 ± 1.86∗ 39.96 ± 2.63∗ 372.38 ± 28.12∗
VIII T. porrifolius 250mg/kg + CCl4 59.30 ± 5.82∗ 28.87 ± 5.65∗ 282.37 ± 17.97∗
∗
𝑃 < 0.05 with respect to the group that received DMSO and CCl4.
(Figure 3(a)). In both cell lines, treating the cells for 48 hours
and at a concentration of 100 𝜇g/mL showed the optimum
activity with around 35% decrease in cell viability (Figures
2(b), 2(c), 3(b), and 3(c)).
The effect of the T. porrifolius methanolic extract on the
proliferation of the MDA-MB-231 and Caco-2 cell lines was
evaluated using the WST-1 proliferation assay. The results,
shown in Figure 4, demonstrate a dose-dependent decrease
in proliferation.The optimal concentration of 100 𝜇g/mL was
again used and, similarly to the viability results, reduced
proliferation by almost 50%. The effect on Caco-2 cells was
less pronounced, consistently with the viability data.
4. Discussion
Reactive oxygen species (ROS) have been associated with
many degenerative diseases and are considered potential
carcinogens. These oxygen-derived free radicals can induce
injury to nuclear DNA, facilitating mutagenesis and leading
to cancer initiation and progression [4]. Antioxidants provide
protection to cellular systems from the harmful effects of
excessive oxidation and consequently contribute to the inhi-
bition ofmany diseases including cardiovascular diseases and
cancer [20].
The antioxidant capacity of the T. porrifolius extract was
tested using in vitro and in vivo assays. In the FRAP assay, the
extract had a value of 659 𝜇mol Fe2+/g dry weight which was
fairly comparable to that of ascorbic acid, 889𝜇mol Fe2+/g.
Song et al. [21] reported the antioxidant capacities of 56
Chinese medicinal plants where the FRAP values ranged
from 0.15 𝜇mol Fe2+/g to 856.9 𝜇mol Fe2+/g. Therefore, T.
porrifolius methanolic extract can be considered to have
a relatively high antioxidant capacity. Similarly, the DPPH
radical scavenging assay revealed high antioxidant activity
(IC
50
= 15.18 𝜇g/mL) that is also comparable to that of
ascorbic acid (IC
50
= 9.13 𝜇g/mL).
Polyphenols are capable of scavenging free radicals by
donating a hydrogen atom and are thus considered efficient
antioxidants in a wide range of oxidation systems [20]. Total
phenolic content of the T. porrifolius methanolic extract
was calculated to be 36.9mg GAE/g of plant extract dry
weight. Studies by Song et al. [21] and Tawaha et al. [22]
showed a range of total phenolic content between 0.12 and
59.6mg GAE/g of plant extract. According to Tawaha et al.
[22], any value greater than 20mg GAE/g of plant extract
was considered to be remarkably high, thus indicating that
the T. porrifolius methanolic extract is a rich source of
polyphenols. Flavonoids are known to have beneficial effects
on a variety of diseases, including cardiovascular diseases and
cancer [23].T. porrifoliusflavonoid content (16.6mgQE/g dry
weight) is considered relatively high when compared to some
Mediterranean dietary plants [24] reflecting the potential
benefits of the plant.
Antioxidant enzymes constitute the first line of defense
against oxidative stress and damage caused by free radicals
[25]. In this study, in vivo data showed that animals treated
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Figure 2: Cytotoxicity of T. porrifolius methanolic extract on MDA-MB-231 cells at 24 and 48 hours of treatment. (a and b) Effect of the
extract on cell viability. (c) Dose response curve of the extract. ∗𝑃 < 0.02 with respect to the group that received only DMSO.
with CCl
4
exhibited a substantial (𝑃 < 0.001) decrease in
the levels of liver antioxidant enzymes as compared to con-
trol animals, which is consistent with previous reports in
the literature [26]. Treatment with T. porrifolius methanolic
extract appeared to have a positive impact on the level of liver
antioxidant enzymes when given to normal rats or to rats
subjected to liver damage.The effect was most remarkable on
the CAT levels where normal animals receiving the extract
(50 and 250mg/kg, groups II and III) exhibited 22.6 and
78.2% increase in the level of this enzyme, respectively. Also,
in the CCl
4
-treated groups (VI, VII, and VIII), the extract
raised the CAT levels by 72, 124, and 222%, respectively,
compared to the control group. The effects of the extract
were less pronounced on the levels of SOD and GST enzymes
whereby group II increased SOD and GST levels by only 13
and 16% and group III by only 27 and 29%. Similarly, the
extract increased SOD levels by 23, 37, and 68% in the CCl
4
-
treated groups (VI, VII, and VIII), respectively. As for GST,
only the 100 and 250mg/kg body weight doses resulted in
an increment of 36 and 149%, respectively, as compared to
the control group. HPLC analysis in this study revealed the
presence of quercetin, luteolin, gallic acid, and chlorogenic
acid, which is consistent with previous reports [27–31]. Gallic
acid and chlorogenic acid have been reported to possess
antioxidant [32–34] and hepatoprotective activity against
CCl
4
-induced liver damage [35, 36]. Similarly, quercetin and
luteolin have also been shown to possess antioxidant activity
[37, 38].
The effect of the T. porrifoliusmethanolic extract on liver
enzymes (ALT, AST, and LDH) was assessed to evaluate any
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potential hepatic damage. In normal rats, the extract did not
cause any significant change in the level of these enzymes.
However, in the CCl
4
-treated groups, all used doses of the
extract were able to protect the liver and reverse the enzyme
levels to normal especially with the 250mg/kg dose. Jadhav
et al. [39] reported similar hepatoprotection against CCl
4
while using silymarin (a reference drug) at a concentration
of 200mg/kg, an effect analogous to the 250mg/kg dose of T.
porrifoliusmethanolic extract.
The anticancer effect of the methanolic extract of T.
porrifolius was investigated in vitro on breast (MDA-MB-
231) and colorectal (Caco-2) adenocarcinoma cell lines. The
present data showed an antiproliferative effect on both cell
lines in a time- and dose-dependent manner. In the WST-
1 proliferation assay, a statistically significant decrease in
proliferation was recorded by the highest dose of the extract
(100 𝜇g/mL). This effect was slightly greater in the MDA-
MB-231 cells with maximum inhibition of around 40%
observed at 24 hrs after treatment.The Trypan Blue exclusion
method showed that the extract increases cell death at this
concentration. Hence, the decrease in metabolically active
cells as revealed in the WST-1 assay might be due to a
positive effect of the extract on cell death. The anticancer
property of T. porrifolius could be attributed to its relatively
high flavonoid component and/or its antioxidant effect or
a different mechanism. Antioxidants can decrease oxidative
stress-induced carcinogenesis by inhibiting ROS generation
or through overexpressing antioxidant enzymes.
In addition to their antioxidant activity, flavonoids are
also known to produce antitumor activity through inhibition
of proliferation, metastasis and invasive effects, induction
of apoptosis, suppression of protein tyrosine kinase activity,
and antiangiogenesis [40]. The identified flavonoids and
phenolic acids have been reported to possess anticancer
effects against different types of cancer cells. For example,
chlorogenic acid was shown to inhibit proliferation ofmurine
melanoma, human adenocarcinoma, and uterine carcinoma
cells [41, 42]. Kuntz et al. [43] reported that luteolin and
quercetin displayed antiproliferative effects against colon
cancer cell lines HT-29 and Caco-2. Luteolin has also been
found to be effective against various types of cancer cells
[44, 45]. Inhibition of human colon and breast cancer cells
proliferation by quercetin has been well cited in the literature
[46–50]. Gallic acid was also reported to inhibit proliferation
[51] and induce differentiation [52] and cell cycle delay [53] in
Caco-2 cells. Additionally, gallic acid inhibited the activation
of NF𝜅B resulting in inhibition of target genes involved in
metastasis, antiapoptosis, and angiogenesis [54].
In conclusion, the Tragopogon porrifolius methanolic
extract was shown to possess antioxidant, hepatoprotec-
tive, and anticancer potentials. The antioxidant activity was
demonstrated both in vitro and in vivo. This effect may be
attributed to the relatively high contents of phenols and
flavonoids. The extract at all doses used showed no negative
effects on liver enzymes in normal rats and protected the
liver against CCl
4
-induced toxicity. The anticancer activity
against MDA-MB-231 and Caco-2 cell lines was time- and
dose-dependent and was mediated through inhibition of cell
proliferation and increased cell death. Future work is needed
to characterize the phenolic and flavonoid content as well as
the biologically active compounds.
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